Joseph FraiettaPietro GenoveseSwim Across America, the nonprofit funding innovative clinical trials and patient-centered programs for cancer, awarded $450,000 grants to two of its beneficiaries, Alliance for Cancer Gene Therapy and Dana-Farber Cancer Institute, to support the work of novel gene and base editing techniques used in advanced cancer research, including targeted therapies, immunotherapies, and cellular therapies.
The American Association for Cancer Research will honor the following cancer researchers and physician-scientists during the AACR Annual Meeting 2025, to be held April 25-30 at the McCormick Place Convention Center in Chicago.
Hope S. Rugo has joined City of Hope to lead its Women’s Cancers Program throughout the organization and breast medical oncology division section.
USC Norris Comprehensive Cancer Center, part of Keck Medicine of USC, has opened Keck Medicine of USC–Newport Beach Radiation Oncology and Imaging, a new radiation oncology and imaging center, at 4590 MacArthur Blvd. in Newport Beach, CA.
In the documentary short, “1001 cuts,” Sarah Temkin, a gynecologic oncologist, examines the enduring misogyny of medicine, particularly in the operating room.
Howard Hughes Medical Institute Investigator David R. Liu was awarded the 2025 Breakthrough Prize in Life Sciences for developing two gene-editing technologies—known as base editing and prime editing—which enable the correction or replacement of virtually any genetic mutation, including those that cause countless human genetic diseases.
Ira Mellman was named president of research at the Parker Institute for Cancer Immunotherapy.
Mark Cosentino has joined City of Hope as scientific director of the new Kathleen and Robert Henderson Biorepository, which is designed to be a best-in-class facility that collects and organizes tissue samples and other biological materials across City of Hope’s national system to further boost its cancer and other research.
Filippo Milano, a hematologist-oncologist and clinical researcher, was named the inaugural Endowed Chair in Cord Blood Research at Fred Hutchinson Cancer Center.
Dian Wang, William Tseng, and Brian A. Van Tine were appointed to NRG Oncology’s newly formed Sarcoma Subcommittee. Clifton (Dave) Fuller was named vice chair for NRG’s Imaging Committee.
